Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: A retrospective cohort study

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Zilberberg, Marya D ^a,b   Kollef, Marin H ^c   Arnold, Heather ^c   Labelle, Andrew ^c   Micek, Scott T ^c   Kothari, Smita ^d   Shorr, Andrew F ^e  

^a EviMed Research Group LLC   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

^e WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; VORICONAZOLE;

ADULT; ARTICLE; CANDIDEMIA; COHORT ANALYSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; FEMALE; FUNGUS CULTURE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL COST; HOSPITAL SERVICE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; MORTALITY; NONHUMAN; RETROSPECTIVE STUDY; STATISTICAL MODEL; THERAPY DELAY; AGED; CANDIDIASIS; FUNGEMIA; HEALTH SERVICES RESEARCH; HOSPITAL; MIDDLE AGED; STATISTICS; TREATMENT OUTCOME;

ADULT; AGED; ANTIFUNGAL AGENTS; CANDIDIASIS; COHORT STUDIES; FEMALE; FUNGEMIA; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HOSPITALS; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77954038544     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-150     Document Type: Article

References (19)

1. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007, 20:133-63. 10.1128/CMR.00029-06, 1797637, 17223626.
2. Zilberberg MD, Shorr AF, Kollef MH. Secular trends in candidemia-related hospitalizations in the US, 2000-2005. Infect Control Hosp Epidemiol 2008, 29:978-80. 10.1086/591033, 18715153.
3. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK, . National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the Natioanl Healthcare Safety Network at the Centes for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidmiol 2008, 29:996-1011. National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities.
4. Snydman DR. Shifting patterns in the epidemiology of nosocomial Candida infections. Chest 2003, 123:500-503.
5. Nguyen MH, Peacock JE, Morris AJ, Tanner DC, Nguyen ML, Snydman DR, Wagener MM, Rinaldi MG, Yu VL. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996, 100:617-23. 10.1016/S0002-9343(95)00010-0, 8678081.
6. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005, 49:3640-5. 10.1128/AAC.49.9.3640-3645.2005, 1195428, 16127033.
7. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study. Clin Infect Dis 2006, 43:25-31. 10.1086/504810, 16758414.
8. Labelle AJ, Micek ST, Roubinian N, Kollef MH. Treatment-related risk factors for hospital mortality in Candida bloodstream infections. Crit Care Med 2008, 36:2967-72. 10.1097/CCM.0b013e31818b3477, 18824910.
9. Shorr AF, Gupta V, Sun X, Johannes RS, Spalding J, Tabak YP. Burden of early-onset candidemia: analysis of culture-positive bloodstream infections from a large U.S. database. Crit Care Med 2009, 37:2519-26. 10.1097/CCM.0b013e3181a0f95d, 19623050.
10. Smith PB, Morgan J, Benjamin JD, Fridkin SK, Sanza LT, Harrison LH, Sofair AN, Huie-White S, Benhamin DK. Excess costs of hospital care associated with neonatal candidemia. Pediatr Infect Dis J 2007, 26:197-200. 10.1097/01.inf.0000253973.89097.c0, 17484214.
11. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005, 41:1232-9. 10.1086/496922, 16206095.
12. Leon C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, León MA, . EPCAN Study Group A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006, 34:730-7. 10.1097/01.CCM.0000202208.37364.7D, 16505659, EPCAN Study Group.
13. Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, Nucci M, PAppas PG, Bradley ME, Major S, Zimmer L, Wallace D, Dismukes WE, Rex JH. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007, 26:271-6. 10.1007/s10096-007-0270-z, 17333081.
14. Faiz S, Neale B, Rios E, Campos T, Parsley E, Patel B, Ostrosky-Zeichner L. Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit. Eur J Clin Microbiol Infect Dis 2009, 28:689-92. 10.1007/s10096-008-0666-4, 19011913.
15. Shorr AF, Micek ST, Jackson WL, Kollef MH. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs?. Crit Care Med 2007, 35:1257-62. 10.1097/01.CCM.0000261886.65063.CC, 17414080.
16. Micek ST, Roubinian N, Heuring T, Bode M, Williams J, Harrison C, Murphy T, Prentice D, Ruoff BE, Kollef MH. Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med 2006, 34:2707-13. 10.1097/01.CCM.0000241151.25426.D7, 16943733.
17. Shorr AF, MIcek ST, Kollef MH. Inappropriate therapy for methicillin-resistant Stalhylococcus aureus: resource utilization and cost implications. Crit Care Med 2008, 36:2335-40. 10.1097/CCM.0b013e31818103ea, 18596624.
18. Reiss E, Morrison CJ. Nonculture methods for diagnosis of disseminated candidiasis. Clin Microbiol Rev 1993, 6:311-23. 358291, 8269389.
19. Mean M, Marchetti O, Calandra T. Bench-tobedside review: Candida infections in the intensive care unit. Crit Care 2008, 12:204. 10.1186/cc6212, 2374590, 18279532.